SCHEMBL15568624

SCHEMBL15568624

O=CC(Br)c1cccc(OCCOCCOCCF)c1

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
APP P05067 11/20 0.37
KDM4E B2RXH2 2/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TAAR1 Q96RJ0 1/20 0.36
NPC1 O15118 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
DUT P33316 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6182632 0.77 TP53 (0.46) TSHRKDM4EMAPK1TDP1MAPT
SCHEMBL5312200 0.77 CYSLTR2 (0.53) TSHR
SCHEMBL2552420 0.75 MAOB (0.44) KMT2ASMN1; SMN2
SCHEMBL16432400 0.73 MAOB (0.57) KDM4EKMT2ASMN1; SMN2ALDH1A1
SCHEMBL22491503 0.73 MAOB (0.53) APPKDM4EMAPK1TDP1KMT2A
SCHEMBL15567141 0.72 ALDH1A1 (0.44) APPKDM4EKMT2ANPC1MAPT
SCHEMBL6988479 0.72 DRD1 (0.49) TDP1MEN1KMT2ANPC1MAPT
SCHEMBL380929 0.71 CHRM2 (0.49) ALDH1A1
SCHEMBL2420284 0.71 SLC22A12 (0.42) TDP1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL21495026 0.71 CHRM2 (0.42) TSHRMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2885306-A1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE F. Hoffmann-La Roche AG (CH) 2015-06-24 EP disclosed
WO-2014026881-A1 IMIDAZO[2,1]THIAZOL-3-ONE DERIVATIVES USEFUL AS DIAGNOSTIC AGENTS FOR ALZHEIMER'S DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2014-02-20 WO disclosed